Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07402642Not ApplicableRecruiting

Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome

Role: collaborator

NCT07100288Recruiting

Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer

Role: lead

NCT06918444Not ApplicableRecruiting

Evaluation of the WARIFA App and Its Impact on Healthy Lifestyle

Role: collaborator

NCT06706544Phase 2Recruiting

Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy

Role: collaborator

NCT06607159Not ApplicableActive Not Recruiting

Childhood Obesity Prevention Project in Gran Canaria

Role: lead

NCT05314907Not ApplicableUnknown

Acceptability of Self-sampling for Cervical Cancer Screening

Role: collaborator

NCT02860325Not ApplicableCompleted

NIV-NAVA Versus Nasal Continuous Positive Airway Pressure (nCPAP) or Non Synchronized NIPPV

Role: lead

All 7 trials loaded